Multicomponent IOL provides excellent vision

Article

Multicomponent IOL implantation is safe, easy and provides excellent vision, according to a recent case series.

Multicomponent IOL implantation is safe, easy and provides excellent vision, according to a recent case series.

Dr Portaliou et al., Institute of Vision and Optics, University of Crete School of Medicine, Heraklion, Crete, Greece, conducted an initial evaluation of six patients who underwent routine cataract surgery and multicomponent IOL implantation. Surgical implantation technique, the manufacturing feasibility of the IOL and the incidence of interlenticular fibrosis were all evaluated.

There were no intraoperative or postoperative complications and no cases of interlenticular fibrosis. The outcomes produced no statistically significant differences in endothelial cell density, anterior chamber depth or pachymetry readings throughout the two-year study.

Multicomponent IOL implantation is an efficient, successful and safe procedure for patients undergoing routine cataract surgery.

To find out more please visit the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.